Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa® than with warfarin
- Details
- Category: Boehringer Ingelheim

Novo Nordisk second best in the world at providing access to medicine
- Details
- Category: Novo Nordisk

Bristol-Myers Squibb to construct a new large-scale biologics manufacturing facility in Ireland
- Details
- Category: Bristol-Myers Squibb

AstraZeneca announces initiation of development programme for BRILINTA® reversal agent
- Details
- Category: AstraZeneca

Roche to invest 450 million Swiss Francs in new diagnostic manufacturing facility in China
- Details
- Category: Roche

Bayer operationally strong - strategic focus on Life Science businesses
- Details
- Category: Bayer

AstraZeneca launches Healthy Heart Africa programme to address hypertension in Africa
- Details
- Category: AstraZeneca

More Pharma News ...
- Bristol-Myers Squibb enters into agreement that provides an exclusive option to acquire F-star Alpha Ltd. and its novel HER2-targeted therapy
- AstraZeneca strengthens partnership with the University of Cambridge
- Roche delivers solid sales growth for the first nine months of 2014
- Novo Nordisk second best science employer in the world
- Bayer supports World Thrombosis Day as founding global partner
- Positive results from Phase IIb benralizumab study in severe asthma
- New data on the global economic impact and burden of preventable blindness and vision impairment